Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a
2010

Impact of miR-92a on Acute Leukemia

Sample size: 91 publication Evidence: moderate

Author Information

Author(s): Ohyashiki Junko H, Umezu Tomohiro, Kobayashi Chiaki, Hamamura Ryoko S, Tanaka Masami, Kuroda Masahiko, Ohyashiki Kazuma

Primary Institution: Tokyo Medical University

Hypothesis

Does miR-92a expression in plasma reflect its levels in leukemia cells?

Conclusion

miR-92a expression in leukemia cells could be a prognostic factor in ALL patients.

Supporting Evidence

  • miR-92a expression was significantly lower in acute leukemia compared to normal controls.
  • ALL patients with overexpressed miR-92a had poor prognoses.
  • The cell to plasma ratio of miR-92a was significantly higher in both AML and ALL cells compared to healthy controls.

Takeaway

This study looks at a molecule called miR-92a in leukemia patients to see if it can help doctors understand the disease better.

Methodology

The study involved measuring miR-92a levels in leukemia cells and plasma from 91 patients using reverse transcription polymerase chain reaction.

Limitations

The study could not determine the clinical relevance of miR-92a when analyzing only a cell fraction of AML.

Participant Demographics

Patients aged 17-72 years with untreated, primary acute leukemia.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1756-0500-3-347

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication